| Literature DB >> 36044571 |
Ye Liu1,2, Ruoyu Wang1,2, Jiahui Liu1,2,3, Hui Lu1,2, Haoran Li1,2, Yu Wang1,2, Xiaomeng Ni1,2, Junwei Li1,2,3, Yanmei Guo1,2, Hongwu Ma1,2, Xiaoping Liao1,2, Meng Wang1,2.
Abstract
Genome-scale functional screening accelerates comprehensive assessment of gene function in cells. Here, we have established a genome-scale loss-of-function screening strategy that combined a cytosine base editor with approximately 12,000 parallel sgRNAs targeting 98.1% of total genes in Corynebacterium glutamicum ATCC 13032. Unlike previous data processing methods developed in yeast or mammalian cells, we developed a new data processing procedure to locate candidate genes by statistical sgRNA enrichment analysis. Known and novel functional genes related to 5-fluorouracil resistance, 5-fluoroorotate resistance, oxidative stress tolerance, or furfural tolerance have been identified. In particular, purU and serA were proven to be related to the furfural tolerance in C. glutamicum. A cloud platform named FSsgRNA-Analyzer was provided to accelerate sequencing data processing for CRISPR-based functional screening. Our method would be broadly useful to functional genomics study and strain engineering in other microorganisms.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36044571 PMCID: PMC9432829 DOI: 10.1126/sciadv.abq2157
Source DB: PubMed Journal: Sci Adv ISSN: 2375-2548 Impact factor: 14.957
Fig. 1.Genome-scale functional screening of C. glutamicum with base editor–mediated inactivation library.
(A) Workflow of this work. (B) Statistics of genes with different numbers of sgRNA in the sgRNA library. (C) Distribution of the scored sgRNAs. (D) Correlation analysis between different biological replicates during the construction of the inactivation libraries. Plasmid, sgRNA plasmid library; Transformant, C. glutamicum transformant library after cotransformation of base editor expression plasmid and sgRNA plasmid library; Inactivation, C. glutamicum inactivation library after base editing and base editor expression plasmid curing.
Statistics analysis of each constructed library via NGS.
|
|
|
|
|
| ||
|
|
|
| ||||
|
|
|
|
| |||
| Plasmid (NGG) | 10646744 | 9582402 | 7466 | 2837 | 7220 | 2812 |
| 97.61% | 97.76% | 94.39% | 96.90% | |||
| Plasmid (NGA) | 7673608 | 6963096 | 3887 | 2024 | 3868 | 2020 |
| 99.46% | 98.54% | 98.98% | 98.34% | |||
| Transformant 1 | 10660732 | 10112918 | 11265 | 3036 | 10821 | 3033 |
| 97.47% | 99.84% | 93.63% | 99.74% | |||
| Transformant 2 | 11342596 | 10776907 | 11330 | 3035 | 10868 | 3033 |
| 98.03% | 99.80% | 94.04% | 99.74% | |||
| Transformant 3 | 9731896 | 9249060 | 11256 | 3039 | 10882 | 3035 |
| 97.40% | 99.93% | 94.16% | 99.80% | |||
| Inactivation 1 | 9111468 | 8606431 | 10931 | 3033 | 10528 | 3029 |
| 94.58% | 99.74% | 91.10% | 99.61% | |||
| Inactivation 2 | 9746060 | 9224673 | 11046 | 3034 | 10529 | 3029 |
| 95.58% | 99.77% | 91.10% | 99.61% | |||
| Inactivation 3 | 8551616 | 8088598 | 10929% | 3033 | 10566 | 3027 |
| 94.57% | 99.74% | 91.43% | 99.54% | |||
*Number of genes with at least one sgRNA that read count >0.
†Number of genes with at least one sgRNA that read count ≥20.
‡Mapping ratio to the in silico library.
Fig. 2.Genome-scale functional screening in the presence of 5-FU or 5-FOA.
(A) Pyrimidine metabolism in C. glutamicum. UMP, uridine monophosphate; 5-FdUMP, 5-fluorodeoxyuridine monophosphate. (B) Common enriched genes of three biological replicates determined by sgRNA Sanger sequencing of the picked colonies from the selective culture condition with 5-FU. (C) Volcano plot of sgRNA fitness relative to −log10 (P value) in the presence of 5-FU according to the edgeR-based analysis. (D) Volcano plot of sgRNA fitness relative to −log10 (P value) in the presence of 5-FOA.
Fig. 3.Genome-scale functional screening under oxidative stress.
(A) Volcano plot of sgRNA fitness relative to −log10 (P value) under oxidative stress. (B) Effects of oxyR on oxidative stress tolerance. ΔoxyR, oxyR deletion by the suicide plasmid–mediated allele exchange; oxyRW258*, oxyR inactivation for mutating tryptophan at position 258 to a stop codon by base editing. N = 3 independent experiments. Two-tailed t tests were performed to determine significance levels against the wild-type (WT) strain. **P < 0.01.
Fig. 4.Genome-scale functional screening in the presence of furfural.
(A) Volcano plot of sgRNA fitness relative to −log10 (P value) in the presence of furfural. (B) Effects of purU and serA on furfural tolerance. purUW47*, purU inactivation for mutating tryptophan at position 47 to a stop codon by base editing; serAQ184K, an amino acid transition Q184K in serA introduced by base editing. (C) Enzyme activity assay of PGDH using purified protein. WT, wild-type PGDH; Q184K, PGDH with amino acid transition Q184K. N = 3 independent experiments. Two-tailed t tests were performed to determine the significance levels against the wild-type strain. **P < 0.01 and ***P < 0.001.
Fig. 5.Overview of FSsgRNA-Analyzer.
(A) The architecture of FCsgRNA-Analyzer online service based on Amazon web services. (B) The workflow of FCsgRNA-Analyzer. CDN, content delivery network; VPC, virtual private cloud; ENV, environment.
Strains and plasmids used in this study.
|
|
| |
|
| ||
| General cloning host | TaKaRa | |
| Gene overexpression host | Novagen | |
| Wild-type strain | ATCC | |
|
| ||
| pK18 | Gene deletion/integration vector, | ( |
| pET28a (+) | Expression vector of | Novagen |
| pnCas9(D10A)-AIDTS | pXMJ19 carrying nCas9(D10A)-AID cassette driven by IPTG-inducible promoter | ( |
| pnVQR-Cas9(D10A)-AIDTS | pnCas9(D10A)-AIDTS derivative. D1135V, R1335Q, and T1337R mutations were | ( |
| pgRNA- | pEC-XK99E derivative, carrying gRNA cassette driven by constitutive | ( |
| pgRNA- | pgRNA- | This study |
| pnCas9(D10A)-AID-gRNA- | pnCas9(D10A)-AIDTS derivative, carrying gRNA- | ( |
| pnVQR-Cas9(D10A)-AID-gRNA- | pnCas9(D10A)-AID-gRNA- | ( |
| pK18 | pK18 | This study |
| pK18 | pK18 | This study |
| pK18 | pK18 | This study |
| pK18 | pK18 | This study |
| pK18 | pK18 | This study |
| pK18 | pK18 | This study |
| pK18 | pK18 | This study |
| pET28a- | pET28a(+) derivative, carrying | This study |
| pET28a- | pET28a- | This study |
*KmR and CmR represent resistance to kanamycin and chloramphenicol, respectively.
†Plasmids with sgRNA expression cassette for changed guide sequences are not listed here. A full list of primers used for construction of sgRNA expression plasmids is shown in data S5.